Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-01-10
4:36 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
INTEGRATED CORE STRATEGIES (US) LLC3,131,479
5.1%
-159,307decrease
(-4.84%)
View
2022-12-01
4:07 pm
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
INTEGRATED CORE STRATEGIES (US) LLC3,290,786
5.3%
3,290,786increase
(New Position)
View
2022-06-09
3:20 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
BlackRock Inc.
BLK
2,942,665
4.8%
-55,814decrease
(-1.86%)
View
2022-02-14
4:25 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
Point72 Asset Management, L.P.56,098
0.1%
-2,873,689decrease
(-98.09%)
View
2022-02-14
08:01 am
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
Nantahala Capital Management, LLC2,813,560
5.7%
399,558increase
(+16.55%)
View
2022-02-14
06:40 am
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
BCLS II Equity Opportunities, LP2,847,689
5.8%
147,689increase
(+5.47%)
View
2022-02-11
4:12 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
ORBIMED ADVISORS LLC3,956,124
7.9%
-1,059,400decrease
(-21.12%)
View
2022-02-10
5:03 pm
Purchase
13DAeglea BioTherapeutics, Inc.
AGLE
BAKER BROS. ADVISORS LP5,044,478
9.9%
143,288increase
(+2.92%)
View
2022-02-10
4:13 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
ELI LILLY & Co
LLY
1,526,516
3.1%
-1,042,027decrease
(-40.57%)
View
2022-02-10
11:14 am
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
PICTET ASSET MANAGEMENT SA2,468,129
5%
2,468,129increase
(New Position)
View
2022-02-10
09:01 am
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
ADAGE CAPITAL PARTNERS GP, L.L.C.1,000,000
2.03%
-1,992,000decrease
(-66.58%)
View
2022-02-03
4:41 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
BlackRock Inc.
BLK
2,998,479
6.1%
-241,496decrease
(-7.45%)
View
2021-12-16
4:32 pm
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
SUVRETTA CAPITAL MANAGEMENT, LLC2,571,000
5.2%
2,571,000increase
(New Position)
View
2021-03-19
4:07 pm
Purchase
13DAeglea BioTherapeutics, Inc.
AGLE
BAKER BROS. ADVISORS LP4,901,190
9.9%
8,657increase
(+0.18%)
View
2021-03-05
5:17 pm
Unchanged
13DAeglea BioTherapeutics, Inc.
AGLE
BAKER BROS. ADVISORS LP4,892,533
9.9%
0
(Unchanged)
View
2021-02-16
4:53 pm
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
BAKER BROS. ADVISORS LP4,892,533
9.9%
3,178,929increase
(+185.51%)
View
2021-02-16
3:14 pm
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
Point72 Asset Management, L.P.2,929,787
6.1%
41,811increase
(+1.45%)
View
2021-02-16
10:21 am
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
Nantahala Capital Management, LLC2,414,002
4.9%
-438,258decrease
(-15.37%)
View
2021-02-12
4:59 pm
Sale
13GAeglea BioTherapeutics, Inc.
AGLE
Lilly Ventures Fund I LLC2,568,543
5.4%
-80,666decrease
(-3.04%)
View
2021-02-12
4:39 pm
Purchase
13GAeglea BioTherapeutics, Inc.
AGLE
ORBIMED ADVISORS LLC5,015,524
10.25%
2,150,000increase
(+75.03%)
View
Goto 0, 1, 2, Next